Seven IPOs and 10 SPACs went public this past week. The IPO pipeline remained active, with 11 IPOs and 22 SPACs submitting initial filings. Phase 2 biotech Kronos Bio (KRON) priced above the range to raise $250 million at a $1.1 billion market cap. The biotech is developing therapies targeting dysregulated transcription factors for leukemia and solid tumor...read more
Landcadia Holdings III, the third blank check company formed by the CEOs of Landry's and Jefferies to acquire an entertainment business, raised $500 million by offering 50 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company is led by CEO and Co-Chairman Tilman Fertitta,...read more
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
US IPO Weekly Recap: Healthcare dominates a 7 IPO week
Seven IPOs and 10 SPACs went public this past week. The IPO pipeline remained active, with 11 IPOs and 22 SPACs submitting initial filings. Phase 2 biotech Kronos Bio (KRON) priced above the range to raise $250 million at a $1.1 billion market cap. The biotech is developing therapies targeting dysregulated transcription factors for leukemia and solid tumor...read more
Fertitta and Handler's third SPAC Landcadia Holdings III prices $500 million IPO at $10
Landcadia Holdings III, the third blank check company formed by the CEOs of Landry's and Jefferies to acquire an entertainment business, raised $500 million by offering 50 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company is led by CEO and Co-Chairman Tilman Fertitta,...read more